Best additional management after non-curative endoscopic resection of esophageal squamous cell carcinoma: a systematic review and meta-analysis

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Arnold M, Laversanne M, Brown LM, et al. Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030. Am J Gastroenterol. 2017;112(8):1247–1255.
   PubMed Web of Science ®Google Scholar
• Japan Esophageal Society. Japanese classification of esophageal cancer. Esophagus. 2017;14:1–36.
   PubMed Web of Science ®Google Scholar
• Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T, et al. Endoscopic submucosal dissection: European society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy. 2015;47(9):829–854.
   PubMed Web of Science ®Google Scholar
• Wright CD, Kucharczuk JC, O’Brien SM, et al. Predictors of major morbidity and mortality after esophagectomy for esophageal cancer: a society of thoracic surgeons general thoracic surgery database risk adjustment model. J Thorac Cardiovasc Surg. 2009;137(3):587–595.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ding H, Chen T, et al. Outcomes of endoscopic submucosal dissection vs esophagectomy for T1 esophageal squamous cell carcinoma in a real-world cohort. Clin Gastroenterol Hepatol. 2019;17(1):73–81.
   PubMed Web of Science ®Google Scholar
• Ishihara R, Arima M, Iizuka T, et al. Endoscopic submucosal dissection/endoscopic mucosal resection guidelines for esophageal cancer. Dig Endosc. 2020;32(4):452–493.
   PubMed Web of Science ®Google Scholar
• Akutsu Y, Uesato M, Shuto K, et al. The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: a retrospective analysis of 295 patients. Ann Surg. 2013;257(6):1032–1038.
   PubMed Web of Science ®Google Scholar
• Yamashina T, Ishihara R, Nagai K, et al. Long-term outcome and metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma. Am J Gastroenterol. 2013;108(4):544–551.
   PubMed Web of Science ®Google Scholar
• Eguchi T, Nakanishi Y, Shimoda T, et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol. 2006;19(3):475–480.
   PubMed Web of Science ®Google Scholar
• National Institute of Cancer. Common terminology criteria for adverse events (CTCAE), version 4.0, DCTD, CTI, NIH, DHHS. Bethesda (MD): NIH Publication; 2009. p. 0–71.
   Google Scholar
• Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in Meta-analyses. Ottawa (Canada): Ottawa Hospital Research Institute; 2021.
   Google Scholar
• Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
   PubMed Web of Science ®Google Scholar
• GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004;328:1490.
   PubMed Web of Science ®Google Scholar
• Goense L, Meziani J, Borggreve AS, et al. Role of adjuvant chemoradiotherapy after endoscopic treatment of early-stage esophageal cancer: a systematic review. Minerva Chir. 2018;73(4):428–436.
   PubMed Web of Science ®Google Scholar
• Tsou YK, Lee CH, Le PH, et al. Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: esophagectomy or chemoradiotherapy? A critical review. Crit Rev Oncol Hematol. 2020;147:102883.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu L, Wang Q, et al. Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell cancer: randomized controlled trial. Endoscopy. 2020;52(12):1066–1074.
   PubMed Web of Science ®Google Scholar
• Shimizu Y, Kato M, Yamamoto J, et al. EMR combined with chemoradiotherapy: a novel treatment for superficial esophageal squamous-cell carcinoma. Gastrointest Endosc. 2004;59(2):199–204.
   PubMed Web of Science ®Google Scholar
• Minashi K, Nihei K, Mizusawa J, et al. Efficacy of endoscopic resection and selective chemoradiotherapy for stage I esophageal squamous cell carcinoma. Gastroenterology. 2019;157(2):382–390.
   PubMed Web of Science ®Google Scholar
• Mochizuki Y, Saito Y, Tsujikawa T, et al. Combination of endoscopic submucosal dissection and chemoradiation therapy for superficial esophageal squamous cell carcinoma with submucosal invasion. Exp Ther Med. 2011;2(6):1065–1068.
   PubMed Web of Science ®Google Scholar
• Motoyama S, Jin M, Matsuhashi T, et al. Outcomes of patients receiving additional esophagectomy after endoscopic resection for clinically mucosal, but pathologically submucosal, squamous cell carcinoma of the esophagus. Surg Today. 2013;43(6):638–642.
   PubMed Web of Science ®Google Scholar
• Ikeda A, Hoshi N, Yoshizaki T, et al. Endoscopic submucosal dissection (ESD) with additional therapy for superficial esophageal cancer with submucosal invasion. Intern Med. 2015;54(22):2803–2813.
   PubMed Web of Science ®Google Scholar
• Kawaguchi G, Sasamoto R, Abe E, et al. The effectiveness of endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer. Radiat Oncol. 2015;10:31.
   PubMed Web of Science ®Google Scholar
• Uchinami Y, Myojin M, Takahashi H, et al. Prognostic factors in clinical T1N0M0 thoracic esophageal squamous cell carcinoma invading the muscularis mucosa or submucosa. Radiat Oncol. 2016;11(1):84.
   PubMed Web of Science ®Google Scholar
• Hamada K, Ishihara R, Yamasaki Y, et al. Efficacy and safety of endoscopic resection followed by chemoradiotherapy for superficial esophageal squamous cell carcinoma: a retrospective study. Clin Transl Gastroenterol. 2017;8(8):e110.
   PubMed Web of Science ®Google Scholar
• Hisano O, Nonoshita T, Hirata H, et al. Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control. Radiat Oncol. 2018;13(1):14.
   PubMed Web of Science ®Google Scholar
• Koterazawa Y, Nakamura T, Oshikiri T, et al. A comparison of the clinical outcomes of esophagectomy and chemoradiotherapy after noncurative endoscopic submucosal dissection for esophageal squamous cell carcinoma. Surg Today. 2018;48(8):783–789.
   PubMed Web of Science ®Google Scholar
• Suzuki G, Yamazaki H, Aibe N, et al. Endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer: choice of new approach. Radiat Oncol. 2018;13(1):246.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Hashimoto S, Mizuno KI, et al. Management decision based on lymphovascular involvement leads to favorable outcomes after endoscopic treatment of esophageal squamous cell carcinoma. Endoscopy. 2018;50(7):662–670.
   PubMed Web of Science ®Google Scholar
• Yoshimizu S, Yoshio T, Ishiyama A, et al. Long-term outcomes of combined endoscopic resection and chemoradiotherapy for esophageal squamous cell carcinoma with submucosal invasion. Dig Liver Dis. 2018;50(8):833–838.
   PubMedGoogle Scholar
• Ikawa T, Ishihara R, Konishi K, et al. Failure patterns after adjuvant chemoradiotherapy following endoscopic resection for superficial esophageal squamous cell carcinoma. Cancer Med. 2019;8(10):4547–4554.
   PubMed Web of Science ®Google Scholar
• Nakajo K, Abe S, Oda I, et al. Impact of the Charlson comorbidity index on the treatment strategy and survival in elderly patients after non-curative endoscopic submucosal dissection for esophageal squamous cell carcinoma: a multicenter retrospective study. J Gastroenterol. 2019;54(10):871–880.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Ueno M, Iizuka T, et al. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma. Dis Esophagus. 2019;32(12):doz023.
   PubMed Web of Science ®Google Scholar
• Kato K, Ito Y, Nozaki I, et al. Parallel-Group controlled trial of surgery versus chemoradiotherapy in patients with stage I esophageal squamous cell carcinoma. Gastroenterology. 2021;161(6):1878–1886.
   PubMed Web of Science ®Google Scholar
• Azad TD, Chaudhuri AA, Fang P, et al. Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer. Gastroenterology. 2020;158(3):494–505.
   PubMed Web of Science ®Google Scholar
• Luketich JD, Pennathur AF, Awais O, et al. Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg. 2012;256(1):95–103.
   PubMed Web of Science ®Google Scholar
• Doosti-Irani A, Holakouie-Naieni K, Rahimi-Foroushani A, et al. A network meta-analysis of the treatments for esophageal squamous cell carcinoma in terms of survival. Crit Rev Oncol Hematol. 2018;127:80–90.
   PubMed Web of Science ®Google Scholar